Cargando…
Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer
BACKGROUND: The epithelial cell adhesion molecule (EpCAM) is overexpressed on most carcinomas. Dependent on the tumour type, its overexpression is either associated with improved or worse patient survival. For ovarian cancer, however, the role of EpCAM remains unclear. METHODS: Cell survival of ovar...
Autores principales: | van der Gun, B T F, Huisman, C, Stolzenburg, S, Kazemier, H G, Ruiters, M H J, Blancafort, P, Rots, M G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590680/ https://www.ncbi.nlm.nih.gov/pubmed/23403823 http://dx.doi.org/10.1038/bjc.2013.45 |
Ejemplares similares
-
Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer
por: van der Gun, B T F, et al.
Publicado: (2011) -
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015) -
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014) -
Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
por: Goossens-Beumer, I J, et al.
Publicado: (2014) -
Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis
por: Warneke, V S, et al.
Publicado: (2013)